CME

AVOID

CME Group Inc.

Financials

2.05

PEGY ratio

Rank #419

Why This Matters

This stock appears overvalued relative to its growth and dividend yield. Moderate projected growth of 10.0% annually. Pays a 1.8% dividend yield.

CME trades at 24.3x earnings against 10.0% growth + 1.8% yield (PEGY 2.05). The valuation appears stretched relative to the available growth and income.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

• Growth rate derived from historical CAGR — limited analyst coverage.

Scan date: 2026-04-24

Valuation

24.3x

P/E Ratio

Growth

10.0%

5yr EPS

Income

1.8%

Div Yield

PEGY Components

PEGY Score2.05

Denominator11.8%

EPS (TTM)$11.72

Market Data

Price$285.06

ExchangeNASDAQ

S&P 500Nasdaq 100

What Changed

PEGY Score

1.43→2.05(+0.62)

Zone

Hold→Avoid

Rank

#297→#419(122 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Financials

PEGY History — 90 days

I Want to Invest Not Right Now

Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only